Law360, New York (August 23, 2012, 5:20 PM ET) -- A Pennsylvania federal judge on Wednesday said buyers of reagents used in blood tests had satisfied the requirements to certify a class in an action alleging that a Johnson & Johnson unit conspired with another company to fix prices on the reagents.
U.S. District Judge Jan E. DuBois certified a class of direct purchasers that claim in the multidistrict litigation that J&J's Ortho-Clinical Diagnostics Inc. colluded with Immucor Inc. to raise prices on traditional blood reagents, which, among other purposes, are often used by hospitals and...
Purchaser Class Certified In J&J Blood Test Antitrust MDL
To view the full article, take a free trial now.
